- Home
- REZI vs XENE Comparison
REZI vs XENE Comparison
Compare REZI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REZI
- XENE
- Stock Information
- Founded
- REZI 2018
- XENE 1996
- Country
- REZI United States
- XENE Canada
- Employees
- REZI N/A
- XENE N/A
- Industry
- REZI Wholesale Distributors
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- REZI Industrials
- XENE Health Care
- Exchange
- REZI Nasdaq
- XENE Nasdaq
- Market Cap
- REZI 2.8B
- XENE 2.9B
- IPO Year
- REZI N/A
- XENE 2014
- Fundamental
- Price
- REZI $19.66
- XENE $40.73
- Analyst Decision
- REZI
- XENE Strong Buy
- Analyst Count
- REZI 0
- XENE 9
- Target Price
- REZI N/A
- XENE $58.11
- AVG Volume (30 Days)
- REZI 1.2M
- XENE 321.1K
- Earning Date
- REZI 10-30-2024
- XENE 11-06-2024
- Dividend Yield
- REZI N/A
- XENE N/A
- EPS Growth
- REZI N/A
- XENE N/A
- EPS
- REZI 1.18
- XENE N/A
- Revenue
- REZI $6,166,000,000.00
- XENE N/A
- Revenue This Year
- REZI $9.74
- XENE N/A
- Revenue Next Year
- REZI $7.05
- XENE $1,600.02
- P/E Ratio
- REZI $16.37
- XENE N/A
- Revenue Growth
- REZI N/A
- XENE N/A
- 52 Week Low
- REZI $14.20
- XENE $27.99
- 52 Week High
- REZI $23.43
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- REZI 52.42
- XENE 55.45
- Support Level
- REZI $19.10
- XENE $39.27
- Resistance Level
- REZI $20.37
- XENE $41.47
- Average True Range (ATR)
- REZI 0.58
- XENE 1.32
- MACD
- REZI 0.04
- XENE 0.16
- Stochastic Oscillator
- REZI 55.06
- XENE 80.58
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions, and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.